Estrella Immunopharma (ESLAW) Q2 2026 Earnings

May 18Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.19
-0.14
-0.1
-0.05

Details

Expected EPS
-0.084
Actual EPS
-0.05
Surprise EPS
0.03
Surprise Percent
+40.48%

Description

⁨Estrella Immunopharma⁩ (⁦ESLAW⁩) has reported earnings of ⁦-0.05⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts